Jun 18, 2017 - Gilead Sciences executives provide some answers at the Goldman Sachs healthcare conference.
Jun 09, 2017 - A pessimistic view of Gilead Sciences' prospects from a long-time fan of the big biotech.
Jun 08, 2017 - Roche Holdings will no longer collaborate with NewLink Genetics on GDC-0919.
Jun 29, 2017 - Aduro Biotech, Inc. (ADRO) has announced initiation of a phase II study to evaluate a combination therapy of its lead candidate, CRS-207, in combination with Keytruda, for treatment of patients with pleural mesothelioma (MPM).
Jul 15, 2017 - You don't need a million bucks to have a winning portfolio.
Jul 02, 2017 - Is Agenus or Kite Pharma the better oncology stock to own right now?
Jul 21, 2017 - Calthera Biosciences, Aurinia Pharmaceuticals, and Esperion Therapeutics are some of the hottest biotech stocks in 2017, and catalysts that are on deck could suggest there's more upside ahead.
Aug 19, 2017 - Shares of Geron Corporation, Rigel Pharmaceuticals Inc., and Agenus Inc. appear to be trading for much less than they could be worth.
Aug 22, 2017 - Eli Lilly, Incyte, and Johnson & Johnson could have the most exciting late-stage oncology candidates.
Aug 31, 2017 - Incyte Corp. (INCY) and Eli Lilly & Co. (LLY) announced Wednesday morning that will resubmit the New Drug Application for baricitinib before the end of January 2018. The decision was made after discussions with the FDA.